Cargando…
ET-12 ANTI-VEGF THERAPY WITH KETOGENIC DIET AGAINST GLIOBLASTOMA IN MOUSE MODEL
NTRODUCTUION: Malignant glioma cells critically depend on glucose as the main energy source to survive and sustain their aggressive properties. The ketogenic diet (KD) has been proposed as a complementary therapy for treatment of malignant gliomas. VEGF inhibitor (bevacizumab) decreases blood supply...
Autores principales: | Sasayama, Takashi, Maeyama, Masahiro, Tanaka, Kazuhiro, Fujita, Yuichi, Hashiguchi, Mitsuru, Irino, Yasuhiro, Kohmura, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213401/ http://dx.doi.org/10.1093/noajnl/vdz039.042 |
Ejemplares similares
-
Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
por: Maeyama, Masahiro, et al.
Publicado: (2021) -
CBMS-07 SERINE SYNTHESIS AND ONE-CARBON METABOLISM IN GLIOMA CELLS TO SURVIVE GLUTAMINE STARVATION
por: Tanaka, Kazuhiro, et al.
Publicado: (2019) -
Multi‐marker algorithms based on CXCL13, IL‐10, sIL‐2 receptor, and β2‐microglobulin in cerebrospinal fluid to diagnose CNS lymphoma
por: Maeyama, Masahiro, et al.
Publicado: (2020) -
Glioma cells require one-carbon metabolism to survive glutamine starvation
por: Tanaka, Kazuhiro, et al.
Publicado: (2021) -
Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)